Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2 [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and effectiveness of ALKS 2680 in Narcolepsy, type 2. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy Type

Drugs mentioned

• ALKS 2680

Snippet

Sponsor: Alkermes, Inc. | Conditions: Narcolepsy Type 2 | Phase 2 | Status: COMPLETED